ストックスクリーナーアプリを入手
50.77
2.08%
-1.08
アフターアワーズ：
50.77
Spruce Biosciences Inc (SPRB) 最新ニュース
Price to book forward of Spruce Biosciences, Inc. – NASDAQ:SPRB - TradingView
SPRB Stock Drops After Company Pushes Back Application Submission Timeline For Experimental Sanfilippo Syndrome Therapy - Stocktwits
Spruce Biosciences (SPRB) Joins Russell 3000 Index - GuruFocus
Spruce Biosciences Joins the Russell 3000® Index - BioSpace
Spruce Biosciences, Inc.(NasdaqCM:SPRB) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to Russell 2500 Growth Benchmark - marketscreener.com
Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to Russell 2000 Index - marketscreener.com
Spruce Biosciences added to Russell 3000 index By Investing.com - Investing.com South Africa
Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to Russell 2000 Value Benchmark - marketscreener.com
Spruce Biosciences, Inc.(NasdaqCM:SPRB) added to Russell Microcap Value Benchmark Index - marketscreener.com
Spruce Biosciences added to Russell 3000 index - Investing.com
Spruce Biosciences, Inc.(NasdaqCM:SPRB) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to Russell 3000E Growth Benchmark - marketscreener.com
Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to Russell Microcap Index - marketscreener.com
Spruce Biosciences, Inc.(NasdaqCM: SPRB) added to Russell 2500 Value Benchmark - marketscreener.com
Price to sales forward of Spruce Biosciences, Inc. – BOATS:SPRB - TradingView
Spruce Biosciences, Inc.(NasdaqCM:SPRB) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Spruce Biosciences Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock RallyEarnings Beat Streak - dars.gov.et
Enterprise value to EBIT forward of Spruce Biosciences, Inc. – BOATS:SPRB - TradingView
Enterprise value to EBITDA forward of Spruce Biosciences, Inc. – BOATS:SPRB - TradingView
Price to earnings forward of Spruce Biosciences, Inc. – NASDAQ:SPRB - TradingView
Spruce Biosciences, Inc. Actuals & Estimates (NASDAQ:SPRB) - TradingView
SPRB Forecast — Price Target — Prediction for 2027 - TradingView
Spruce Biosciences Inc (SPRB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Spruce Biosciences names Agnieszka Jurecka as VP medical affairs - Investing.com UK
Spruce Biosciences names Agnieszka Jurecka as VP medical affairs By Investing.com - Investing.com South Africa
Spruce Biosciences Signals Commercial Shift with Key Hire for Rare Disease Drug - BriefGlance
Spruce Biosciences Appoints Agnieszka Jurecka, M.D., Ph.D., MPH, as Vice President, Medical Affairs - Business Wire
Spruce Biosciences Inc (SPRB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Spruce Biosciences Inc (SPRB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Spruce Biosciences Inc (SPRB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Spruce Biosciences Inc (SPRB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Spruce Biosciences Inc (SPRB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Spruce Biosciences Inc (SPRB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Spruce Biosciences Inc (SPRB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Spruce Biosciences Inc (SPRB) Institutional Confidence - TradingKey
SPRB Initiates Coverage by Guggenheim -- Price Target Announced at $123 - GuruFocus
Guggenheim Initiates Spruce Biosciences(SPRB.US) With Buy Rating, Announces Target Price $123 - Moomoo
BBIO Welcomes New Leadership in Marketing and Finance - GuruFocus
Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller - Investing News Network
Spruce Biosciences names two executives ahead of potential FDA decision By Investing.com - Investing.com Nigeria
Spruce Biosciences names two executives ahead of potential FDA decision - Investing.com
Spruce Biosciences Appoints Eric Jordan and Tina Gullotta to Leadership Roles Ahead of Potential TA-ERT Launch - citybiz
Spruce Biosciences Builds Its Commercial War Chest for a Rare Disease Bet - BriefGlance
SPRB Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive SentimentEarnings Cycle Outlook - newsline.com
SPRB News | SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) - ChartMill
SPRB Initiated Coverage by Jones Trading -- Rating Set to Buy - GuruFocus
Jones Trading initiates Spruce Biosciences stock with buy rating on therapy potential By Investing.com - Investing.com Australia
Spruce Biosciences (SPRB) Reports Promising Long-Term Results fo - GuruFocus
Jones Trading initiates Spruce Biosciences stock with buy rating on therapy potential - Investing.com UK
Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B Presented at the 18th International MPS Symposium - Investing News Network
1.17%
2.48%
大文字化:
|
ボリューム (24 時間):